Apixaban Concentration with and without Coadministration of Carbamazepine: A Case with No Apparent Interaction.
Autor: | Evanger N; BScPharm, is with Pharmacy Services, University of Alberta Hospital, Alberta Health Services, Edmonton, Alberta., Szkotak A; MD, PhD, is with Laboratory Services, University of Alberta Hospital, Alberta Health Services, Edmonton, Alberta., Stang L; MLT, is with Laboratory Services, University of Alberta Hospital, Alberta Health Services, Edmonton, Alberta., Bungard TJ; BSP, PharmD, is with the Division of Cardiology, University of Alberta, Edmonton, Alberta. |
---|---|
Jazyk: | angličtina |
Zdroj: | The Canadian journal of hospital pharmacy [Can J Hosp Pharm] 2017 Nov-Dec; Vol. 70 (6), pp. 463-467. Date of Electronic Publication: 2017 Dec 21. |
DOI: | 10.4212/cjhp.v70i6.1714 |
Abstrakt: | Competing Interests: Competing Interests: Tammy Bungard has received honoraria from Bayer and Bristol Myers Squibb-Pfizer and has also received unrestricted grants from Bristol Myers Squibb-Pfizer and Bayer, all for activities unrelated to this article. Artur Szkotak received a grant from Alexion Pharmaceuticals for work unrelated to this article. Norelle Evanger and Linda Stang have no competing interests to report. |
Databáze: | MEDLINE |
Externí odkaz: |